Literature DB >> 10608897

Serine 157, a retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARalpha heterodimerization and transcriptional activity.

M H Delmotte1, A Tahayato, P Formstecher, P Lefebvre.   

Abstract

Retinoic acid (RA) regulation of cellular proliferation and differentiation is mediated, at least in part, through two related nuclear receptors, RAR and RXR. RA-induced modulation of gene expression leads generally to cellular differentiation, whereas stimulation of the protein kinase C (PKC) signaling pathway is associated with cellular proliferation. Pursuant to our discovery that prolonged activation of PKCs induced a strong decrease in RA responsiveness of a retinoid-inducible reporter gene, we have further investigated the connections between these two signaling pathways. We demonstrate that PKC isoforms alpha and gamma are able to phosphorylate human RARalpha (hRARalpha) in vitro on a single serine residue located in the extended DNA binding domain (T box). The introduction of a negative charge at this position (serine 157) strongly decreased hRARalpha transcriptional activity, whereas a similar mutation at other PKC consensus phosphorylation sites had no effect. The effect on transcriptional activation was correlated with a decrease in the capacity of hRARalpha to heterodimerize with hRXRalpha. Thus hRARalpha is a direct target for PKCalpha and gamma, which may control retinoid receptor transcriptional activities during cellular proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10608897     DOI: 10.1074/jbc.274.53.38225

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 2.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

3.  Retinoic acid receptor alpha1 variants, RARalpha1DeltaB and RARalpha1DeltaBC, define a new class of nuclear receptor isoforms.

Authors:  A Parrado; G Despouy; R Kraïba; C Le Pogam; S Dupas; M Choquette; M Robledo; J Larghero; H Bui; I Le Gall; C Rochette-Egly; C Chomienne; R A Padua
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

4.  Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.

Authors:  Harish Srinivas; Dianren Xia; Nicole L Moore; Ivan P Uray; Heetae Kim; Long Ma; Nancy L Weigel; Powel H Brown; Jonathan M Kurie
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

5.  An ATRActive future for differentiation therapy in AML.

Authors:  Daniel E Johnson; Robert L Redner
Journal:  Blood Rev       Date:  2015-01-21       Impact factor: 8.250

Review 6.  PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol.

Authors:  Devina Mehta; Kamal D Mehta
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-01-19       Impact factor: 4.052

7.  Serine 350 of human pregnane X receptor is crucial for its heterodimerization with retinoid X receptor alpha and transactivation of target genes in vitro and in vivo.

Authors:  Yue-Ming Wang; Sergio C Chai; Wenwei Lin; Xiaojuan Chai; Ayesha Elias; Jing Wu; Su Sien Ong; Satyanarayana R Pondugula; Jordan A Beard; Erin G Schuetz; Su Zeng; Wen Xie; Taosheng Chen
Journal:  Biochem Pharmacol       Date:  2015-06-25       Impact factor: 5.858

8.  A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor.

Authors:  Satyanarayana R Pondugula; Cynthia Brimer-Cline; Jing Wu; Erin G Schuetz; Rakesh K Tyagi; Taosheng Chen
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

9.  Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter.

Authors:  Madjid Benkoussa; Céline Brand; Marie-Hélène Delmotte; Pierre Formstecher; Philippe Lefebvre
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor.

Authors:  Wenqi Cui; Xunan Shen; Emre Agbas; Brandon Tompkins; Hadley Cameron-Carter; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2020-03-23       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.